Back to company

CAND.PHARM. POVL M. ASSENS FOND: Financial statements 2017

CVR: 14536604

CAND.PHARM. POVL M. ASSENS FOND (CVR 14536604) has filed annual accounts for 2017. In 2017, the company reported revenue of DKK 0 and a net result of DKK 5,195,201 compared with DKK 5,087,572 the year before. Equity amounted to DKK 101,646,943. The solvency ratio was 98.5%. The company had 32 employees in the financial year.

Revenue
0 kr.
Gross Profit
0 kr.
Profit/Loss
5,195,201 kr.
Equity
101,646,943 kr.
Total Assets
103,207,530 kr.
Employees
32

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2017005.2 mio.101.6 mio.32
2016005.1 mio.97.2 mio.29
2015006.2 mio.89.2 mio.31
2014006.9 mio.86.3 mio.-
2013003.9 mio.82.4 mio.28

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like CAND.PHARM. POVL M. ASSENS FOND

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2017

Ole Kilsgaard leaves the board of CAND.PHARM. POVL M. ASSENS FONDNov 21, 2017

As of November 21, 2017, Ole Kilsgaard has left the board of directors of CAND.PHARM. POVL M. ASSENS FOND.

CAND.PHARM. POVL M. ASSENS FOND: The 2016 annual report is outMay 5, 2017

CAND.PHARM. POVL M. ASSENS FOND has published its annual report for 2016. Revenue came to DKK 0, and the net result was DKK 5,087,572.

About CAND.PHARM. POVL M. ASSENS FOND

CAND.PHARM. POVL M. ASSENS FOND is a Danish company of the type Erhvervsdrivende fond based in Glostrup, founded in 1999. The company is registered under the industry Støtteaktiviteter relateret til sygdomsbekæmpende, sociale og velgørende formål. The company has 0 employees. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 13,153,000 compared with DKK 11,790,112 the year before. Equity amounted to DKK 128,614,000.